Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd., a foreign private issuer, for the month of February 2021. The filing, dated February 25, 2021, serves primarily to incorporate a press release issued on the same date as Exhibit 99.1. The registrant is based in Jerusalem, Israel, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute a press release and does not contain a financial statement or detailed financial data within the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The content is limited to the incorporation of a press release by reference.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for specific guidance, outlook, management commentary, risks, contingencies, or unusual items. While the filing incorporates a press release, the text of that release is not included in the provided input, preventing a summary of its specific content.
Key Facts for Investor Verification
- Verify the content of the press release dated February 25, 2021, which is attached as Exhibit 99.1 but not detailed in this filing text.
- Confirm the incorporation of this report into Registration Statements on Form F-3 (Nos. 333-238988 and 333-239843).
- Note that the Chief Executive Officer, Spiros Jamas, Sc.D., signed the report on behalf of the registrant.